Latest gene delivery Stories
Using modified human stem cells, a team of UC Davis scientists has developed an improved gene therapy strategy that in animal models shows promise as a functional cure for the human immunodeficiency
Former head of rare diseases at Genzyme brings a 20-year track record of delivering successful, innovative products to patients throughout the world PHILADELPHIA, Dec.
Leading gene therapy Company will partner with established market leader to develop a potential new treatment paradigm for hemophilia B PHILADELPHIA, Dec.
New research from a team of European scientists has shown that genetic material is capable of surviving both the hostile environment of suborbital space and the violent passage through Earth’s atmosphere at a high rate of speed.
Dr. Daniel M. Takefman brings 15 years of FDA experience to leading gene therapy company PHILADELPHIA, Nov.
A new stem cell gene therapy is set to begin clinical trials early next year after the technique reportedly cured 18 children who were born without working immune systems due to a condition known as “Bubble Baby” disease.
Dr. Mitchell Gaynor, acclaimed M.D.
Company on track to report Phase 3 data in second half of 2015 PHILADELPHIA, Nov.
LAS VEGAS, Sept.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.